CRTAP Gene Osteogenesis Imperfecta Type 7 Genetic Test
Welcome to DNA Labs UAE, your trusted genetic testing laboratory. Today, we will be discussing the CRTAP Gene Osteogenesis Imperfecta Type 7 Genetic Test. This test is specifically designed to diagnose Osteogenesis Imperfecta Type 7 (OI Type 7) and provide valuable insights into the condition. Let’s dive into the details:
Test Details
The CRTAP gene is associated with Osteogenesis Imperfecta Type 7 (OI Type 7), also known as OI with craniosynostosis. OI is a group of genetic disorders that affect the bones, making them brittle and prone to fractures. OI Type 7 is a rare form of OI characterized by craniosynostosis, which is the premature fusion of the skull bones.
Our state-of-the-art Next-Generation Sequencing (NGS) technology allows us to analyze multiple genes simultaneously, including the CRTAP gene. By conducting this comprehensive genetic test, we can confirm a diagnosis and identify any disease-causing mutations that may be present.
Test Components and Price
Our CRTAP Gene Osteogenesis Imperfecta Type 7 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
After conducting the test, we will deliver the comprehensive report within 3 to 4 weeks. Our NGS technology ensures accurate and reliable results.
Test Type and Doctor
The CRTAP Gene Osteogenesis Imperfecta Type 7 Genetic Test falls under the categories of Osteology, Dermatology, and Immunology Disorders. Our experienced dermatologists will oversee the test and provide expert guidance.
Test Department and Pre-Test Information
This genetic test is conducted in our Genetics department. Before the test, it is important to provide the clinical history of the patient who is undergoing the CRTAP Gene Osteogenesis Imperfecta Type 7 NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the CRTAP Gene Osteogenesis Imperfecta Type 7 NGS Genetic DNA Test gene CRTAP.
Who Can Benefit from the Test?
Genetic testing for OI Type 7 can be beneficial for individuals experiencing symptoms related to the condition. It can also be helpful for family members who may be at risk of carrying the disease-causing mutation. Furthermore, prenatal testing can be conducted in families with a known mutation to determine if the fetus is affected.
It is important to consult with a genetic counselor or healthcare provider to discuss the appropriateness and availability of NGS genetic testing for OI Type 7. They can provide more information about the specific test, its accuracy, limitations, and potential implications for individuals and their families.
At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Contact us today to schedule your CRTAP Gene Osteogenesis Imperfecta Type 7 Genetic Test and gain valuable insights into your genetic makeup.
| Test Name | CRTAP Gene Osteogenesis imperfecta type 7 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CRTAP Gene Osteogenesis imperfecta type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CRTAP Gene Osteogenesis imperfecta type 7 NGS Genetic DNA Test gene CRTAP |
| Test Details |
The CRTAP gene is associated with Osteogenesis imperfecta type 7 (OI type 7), also known as OI with craniosynostosis. OI is a group of genetic disorders that affect the bones, causing them to be brittle and prone to fractures. OI type 7 is a rare form of OI that is characterized by craniosynostosis, which is the premature fusion of the skull bones. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously. In the case of OI type 7, NGS can be used to analyze the CRTAP gene for any potential disease-causing mutations. This type of genetic testing can provide a comprehensive analysis of the gene, helping to confirm a diagnosis and identify any specific mutations that may be present. Genetic testing for OI type 7 can be helpful for individuals who have symptoms suggestive of the condition, as well as for family members who may be at risk of carrying the disease-causing mutation. It can also be used for prenatal testing in families with a known mutation to determine if the fetus is affected. It is important to consult with a genetic counselor or healthcare provider to discuss the appropriateness and availability of NGS genetic testing for OI type 7. They can provide more information about the specific test, its accuracy, limitations, and potential implications for individuals and their families. |
